Psyence Biomedical Ltd. Secures Clinical Research Partnership with Southern Star Research

Reuters
12 Jun
<a href="https://laohu8.com/S/PBM">Psyence Biomedical Ltd</a>. Secures Clinical Research Partnership with Southern Star Research

Psyence Biomedical Ltd. has entered into a significant Master Services Agreement with Southern Star Research Pty Ltd, a renowned provider of contract clinical research services. Under this agreement, signed on May 21, 2025, Southern Star Research will provide clinical research services to support Psyence's business operations in Australia. As part of the agreement, Psyence will act as the local study sponsor for any projects, ensuring adequate clinical trials liability insurance is in place to meet local regulatory requirements. This collaboration aims to advance Psyence's clinical projects effectively and efficiently, leveraging Southern Star's expertise in clinical research.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Biomedical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-053433), on June 11, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10